MCM
AMGN icon

Mainstay Capital Management’s Amgen AMGN Stock Holding History

Mainstay Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.86M Buy
5,131
+90
+2% +$30.8K 0.14% 53
2026
Q1 		$1.77M Buy
5,041
+98
+2% +$34.9K 0.14% 47
2025
Q4 		$1.62M Sell
4,943
-511
-9% -$162K 0.12% 52
2025
Q3 		$1.54M Sell
5,454
-4,865
-47% -$1.41M 0.15% 53
2025
Q2 		$2.88M Buy
10,319
+5,339
+107% +$1.51M 0.14% 58
2025
Q1 		$1.55M Hold
4,980
– – 0.21% 45
2024
Q4 		$1.3M Buy
4,980
+171
+4% +$50.7K 0.2% 47
2024
Q3 		$1.55M Buy
4,809
+1
+0% +$327 0.26% 39
2024
Q2 		$1.5M Buy
4,808
+107
+2% +$31.4K 0.26% 34
2024
Q1 		$1.34M Sell
4,701
-132
-3% -$38.6K 0.25% 42
2023
Q4 		$1.39M Buy
4,833
+984
+26% +$268K 0.26% 33
2023
Q3 		$1.03M Buy
+3,849
New +$961K 0.22% 34
2018
Q4 		– Sell
-500
Closed -$104K – 102
2018
Q3 		$104K Sell
500
-100
-17% -$19.7K 0.07% 142
2018
Q2 		$111K Buy
+600
New +$106K 0.09% 110
2018
Q1 		– Sell
-5
Closed -$1K – 332
2017
Q4 		$1K Buy
+5
New +$885 ﹤0.01% 352

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Mainstay Capital Management's AMGN Position: Q2 2026 in Review

Mainstay Capital Management increased its Amgen (AMGN) stake by 1.8% in Q2 2026, buying an estimated $30.8K and bringing the position to 5,131 shares worth $1.86M. The position accounts for 0.14% of the portfolio, ranked #53.

Mainstay Capital Management first reported a position in AMGN in Q4 2017 and has held it in 15 quarters since. The position peaked at $2.88M in Q2 2025. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Mainstay Capital Management held 5,131 shares of Amgen worth $1.86M as of Q2 2026.
  • Mainstay Capital Management bought 90 Amgen shares in Q2 2026, an estimated $30.8K.
  • Amgen made up 0.14% of Mainstay Capital Management's portfolio in Q2 2026, its #53 holding.
  • Mainstay Capital Management first reported a position in Amgen in Q4 2017 and has held it in 15 quarters since.
  • Mainstay Capital Management's Amgen position peaked at $2.88M in Q2 2025.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Mainstay Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.